Why Rocket Lab’s $2.2 Billion Backlog Isn’t Enough to Halt the Selloff

Rocket Lab has strung together ten flawless launches in ten attempts this year, the most recent on June 27 when an Electron vehicle lifted off from New Zealand’s Launch Complex 1 carrying a Synspective satellite to a 552-kilometer orbit. That mission — the company’s twelfth of 2026 and its 91st overall — underscores the operational reliability the firm touts as its core competitive advantage in the small-satellite market.

Yet for shareholders, reliability hasn’t translated into share-price resilience. The stock closed Friday at $84.54, up 4.77 percent on the day but down nearly 44 percent over the past 30 days. That puts it far below the 52-week high of $151.00. The disconnect between operational momentum and market sentiment is as wide as the gap between the current price and the 50-day moving average of $105.80. The 100-day average sits at $87.70, and while the shares still trade above the 200-day line at $76.30, the relative strength index of 37.2 signals weakness without yet flashing an oversold extreme.

Behind the operational cadence lies a backlog that crossed $2.2 billion at the end of the first quarter. First-quarter revenue came in at $200.3 million, a 63.5 percent year-over-year jump, and management sees second-quarter revenue between $225 million and $240 million. More than 70 missions are already booked on the launch manifest.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

A significant portion of that backlog comes from government contracts. Rocket Lab has been named to the U.S. Space Force’s SB-AMTI program, a multi-billion-dollar pool aimed at building a space-based sensor network. While SpaceX snagged the first major award worth roughly $4 billion, the Space Force is deliberately diversifying its supplier base. Rocket Lab’s inclusion represents a strategic shift from pure launch provider to a fixture of national security infrastructure. The company recently demonstrated its responsiveness by executing the VICTUS-HAZE mission for the Space Force in under 17 hours from call-up to liftoff — a record for rapid space operations.

Commercial demand is equally robust. Beyond the Synspective partnership, which has 17 more flights scheduled through the end of the decade, Rocket Lab is preparing a mission dubbed “The Grain Goddess Provides” for Japanese customer iQPS. That flight will carry the QPS-SAR-13 satellite into a 575-kilometer orbit and would be the eighth iQPS launch out of 15 contracted missions. A firm launch date has yet to be announced. Meanwhile, NASA has booked three Electron rockets for science missions starting in 2027.

Investor nerves, however, remain on edge. The stock’s near-99 percent annualized volatility underscores the market’s jitteriness. Listing on the Nasdaq-100 in late June — a milestone that typically boosts visibility and liquidity — did nothing to stem the slide. On a year-to-date basis, Rocket Lab shares are still up 134 percent, but the trajectory of the past month has tested the patience of even the most loyal bulls.

The coming week will serve as a litmus test. If Rocket Lab confirms the iQPS launch date and the shares respond positively, it could signal that the market is beginning to reward operational dependability. If the stock continues to drift, the 200-day moving average at $76.30 becomes the last line of defense before a deeper correction — regardless of how many rockets are in the air.

Ad

Rocket Lab USA Stock: New Analysis - 28 June

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

en | US7731221062 | WHY | boerse | 69643049 |